These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 34676804)

  • 21. Combination of CD160 and CD200 as a useful tool for differential diagnosis between chronic lymphocytic leukemia and other mature B-cell neoplasms.
    Lesesve JF; Tardy S; Frotscher B; Latger-Cannard V; Feugier P; De Carvalho Bittencourt M
    Int J Lab Hematol; 2015 Aug; 37(4):486-94. PubMed ID: 25470765
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Utility of CD43 and CD200 in Differentiating Chronic Lymphocytic Leukemia from Other Mature B-Cell Neoplasms: A Cross Sectional Study.
    Kannan N; Dass J; Parikh H; Tiwari S; Viswanathan GK; Aggarwal M; Kumar P; Dhawan R; Seth T; Tyagi S; Mahapatra M
    Indian J Hematol Blood Transfus; 2024 Jul; 40(3):437-442. PubMed ID: 39011261
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.
    Plosker GL; Figgitt DP
    Drugs; 2003; 63(8):803-43. PubMed ID: 12662126
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pan B-cell markers are not redundant in analysis of chronic lymphocytic leukemia (CLL).
    Monaghan SA; Peterson LC; James C; Marszalek L; Khoong A; Bachta DJ; Karpus WJ; Goolsby CL
    Cytometry B Clin Cytom; 2003 Nov; 56(1):30-42. PubMed ID: 14582135
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantitative assessment of informative immunophenotypic markers increases the diagnostic value of immunophenotyping in mature CD5-positive B-cell neoplasms.
    Starostka D; Kriegova E; Kudelka M; Mikula P; Zehnalova S; Radvansky M; Papajik T; Kolacek D; Chasakova K; Talianova H
    Cytometry B Clin Cytom; 2018 Jul; 94(4):576-587. PubMed ID: 29220870
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Positive predictive value of CD200 positivity in the differential diagnosis of chronic lymphocytic leukemia.
    Sorigue M; Magnano L; Miljkovic MD; Nieto-Moragas J; Santos-Gomez M; Villamor N; Junca J; Morales-Indiano C
    Cytometry B Clin Cytom; 2020 Sep; 98(5):441-448. PubMed ID: 31692239
    [TBL] [Abstract][Full Text] [Related]  

  • 27. T-helper cell regulation of CD45 phosphatase activity by galectin-1 and CD43 governs chronic lymphocytic leukaemia proliferation.
    Imbery JF; Heinzelbecker J; Jebsen JK; McGowan M; Myklebust C; Bottini N; Stanford SM; Skånland SS; Tveita A; Tjønnfjord GE; Munthe LA; Szodoray P; Nakken B
    Br J Haematol; 2022 Aug; 198(3):556-573. PubMed ID: 35655388
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antigen modulation followed by quantitative flow cytometry of B-chronic lymphocytic leukemia cells after treatment.
    Kusenda J; Babusíková O
    Neoplasma; 2004; 51(2):97-102. PubMed ID: 15190418
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression patterns of CD200 and CD148 in leukemic B-cell chronic lymphoproliferative disorders and their potential value in differential diagnosis.
    Fan L; Miao Y; Wu YJ; Wang Y; Guo R; Wang L; Shen AL; Chen YY; Xu W; Li JY
    Leuk Lymphoma; 2015; 56(12):3329-35. PubMed ID: 25791119
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of CD43 in chronic lymphoproliferative leukemias.
    Sorigue M; Juncà J; Sarrate E; Grau J
    Cytometry B Clin Cytom; 2018 Jan; 94(1):136-142. PubMed ID: 28073173
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of immunophenotyping in differential diagnosis of chronic lymphocytic leukemia.
    Ivancević TD; Kurtović NK; Knezević V; Bogdanović A; Mihaljević B; Bozić B; Gotić M
    Srp Arh Celok Lek; 2014; 142(3-4):197-203. PubMed ID: 24839775
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Leukemic phase of B-cell lymphomas mimicking chronic lymphocytic leukemia and variants at presentation.
    Nelson BP; Variakojis D; Peterson LC
    Mod Pathol; 2002 Nov; 15(11):1111-20. PubMed ID: 12429788
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnostic significance of CD20 and FMC7 expression in B-cell disorders.
    Delgado J; Matutes E; Morilla AM; Morilla RM; Owusu-Ankomah KA; Rafiq-Mohammed F; del Giudice I; Catovsky D
    Am J Clin Pathol; 2003 Nov; 120(5):754-9. PubMed ID: 14608903
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunophenotype of hairy-cell leukaemia after cold polymerization of methyl-methacrylate embeddings from 50 diagnostic bone marrow biopsies.
    Kreft A; Büsche G; Bernhards J; Georgii A
    Histopathology; 1997 Feb; 30(2):145-51. PubMed ID: 9067739
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunophenotyping of Chronic Lymphocytic Leukemia.
    Falay M; Özet G
    Clin Lab; 2017 Oct; 63(10):1621-1626. PubMed ID: 29035453
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The utility of CD200 expression and modified Matutes score in the diagnostic differentiation of mantle cell lymphoma and chronic lymphocytic leukemia using flow cytometry.
    Myles N; Giri P; Chim I; Kodituwakku A
    Leuk Lymphoma; 2021 Feb; 62(2):504-506. PubMed ID: 31559884
    [No Abstract]   [Full Text] [Related]  

  • 37. A novel differential diagnosis algorithm for chronic lymphocytic leukemia using immunophenotyping with flow cytometry.
    Ozdemir ZN; Falay M; Parmaksiz A; Genc E; Beyler O; Gunes AK; Ceran F; Dagdas S; Ozet G
    Hematol Transfus Cell Ther; 2023; 45(2):176-181. PubMed ID: 35216960
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CD200 expression may help in differential diagnosis between mantle cell lymphoma and B-cell chronic lymphocytic leukemia.
    Palumbo GA; Parrinello N; Fargione G; Cardillo K; Chiarenza A; Berretta S; Conticello C; Villari L; Di Raimondo F
    Leuk Res; 2009 Sep; 33(9):1212-6. PubMed ID: 19230971
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of CD200 in differential diagnosis of mature B-cell neoplasm.
    Rahman K; Kumar P; Gupta R; Singh MK; Nityanand S
    Int J Lab Hematol; 2017 Aug; 39(4):384-391. PubMed ID: 28422443
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Immunophenotyping of B chronic lymphoproliferative syndromes (CLL excluded): confrontation with the histology].
    El Borgi W; Ben Salah N; Ben Lakhal F; Makni L; Gouider E; Hafsia R
    Ann Biol Clin (Paris); 2013; 71(6):693-7. PubMed ID: 24342790
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.